Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling.

[1]  J. Petrie,et al.  Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review. , 2018, Clinical science.

[2]  P. Cummins,et al.  Activation of the non-canonical NF-κB/p52 pathway in vascular endothelial cells by RANKL elicits pro-calcific signalling in co-cultured smooth muscle cells. , 2018, Cellular signalling.

[3]  Baoxin Li,et al.  Osteoclast regulation of osteoblasts via RANK-RANKL reverse signal transduction in vitro , 2017, Molecular medicine reports.

[4]  S. E. Park,et al.  Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation , 2017, PloS one.

[5]  R. Blankstein,et al.  The Implication of Coronary Artery Calcium Testing for Cardiovascular Disease Prevention and Diabetes , 2017, Endocrinology and metabolism.

[6]  J. Dyck,et al.  The role of AMPK in cardiomyocyte health and survival. , 2016, Biochimica et biophysica acta.

[7]  L. Wang,et al.  Resveratrol Ameliorated Vascular Calcification by Regulating Sirt-1 and Nrf2. , 2016, Transplantation proceedings.

[8]  G. Sesti,et al.  The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism , 2016, Journal of Translational Medicine.

[9]  Sheng-nan Wu,et al.  Ablation of Adenosine Monophosphate-Activated Protein Kinase α1 in Vascular Smooth Muscle Cells Promotes Diet-Induced Atherosclerotic Calcification In Vivo. , 2016, Circulation research.

[10]  P. Cummins,et al.  Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL. , 2016, Vascular pharmacology.

[11]  Qifu Li,et al.  AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity , 2016, Diabetes.

[12]  J. Kim,et al.  Increased risk for development of coronary artery calcification in insulin-resistant subjects who developed diabetes: 4-year longitudinal study. , 2016, Atherosclerosis.

[13]  T. Szkudelski,et al.  Resveratrol and diabetes: from animal to human studies. , 2015, Biochimica et biophysica acta.

[14]  J. Sara,et al.  Increased plasma BMP-2 levels are associated with atherosclerosis burden and coronary calcification in type 2 diabetic patients , 2015, Cardiovascular Diabetology.

[15]  J. Leopold.  Vascular calcification: Mechanisms of vascular smooth muscle cell calcification. , 2015, Trends in cardiovascular medicine.

[16]  C. Giachelli,et al.  A current understanding of vascular calcification in CKD. , 2014, American journal of physiology. Renal physiology.

[17]  J. Zhan,et al.  Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK/mTOR pathway. , 2014, Experimental cell research.

[18]  Qifu Li,et al.  Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity , 2014, PloS one.

[19]  Yanjie Jia,et al.  Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia , 2013, Neural regeneration research.

[20]  C. Farquharson,et al.  Mechanisms and Clinical Consequences of Vascular Calcification , 2012, Front. Endocrin..

[21]  M. Ramezani,et al.  Evaluation of RANKL/OPG Serum Concentration Ratio as a New Biomarker for Coronary Artery Calcification: A Pilot Study , 2012, Thrombosis.

[22]  B. Viollet,et al.  AMP-activated protein kinase pathway and bone metabolism. , 2012, The Journal of endocrinology.

[23]  A. Ndip,et al.  The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy , 2011, Diabetes.

[24]  Fang Liu,et al.  Effect of high glucose levels on the calcification of vascular smooth muscle cells by inducing osteoblastic differentiation and intracellular calcium deposition via BMP-2/Cbfα-1 pathway , 2010, Journal of Zhejiang University SCIENCE B.

[25]  B. Viollet,et al.  AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. , 2010, Bone.

[26]  J. Ix,et al.  Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. , 2010, Journal of the American Society of Nephrology : JASN.

[27]  R. Kawamori,et al.  Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents. , 2009, Biochemical and biophysical research communications.

[28]  B. Coll,et al.  RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4–Dependent Pathway , 2009, Circulation research.

[29]  Suresh Mathew,et al.  Hyperphosphatemia of chronic kidney disease. , 2008, Kidney international.

[30]  L. Xing,et al.  Functions of RANKL/RANK/OPG in bone modeling and remodeling. , 2008, Archives of biochemistry and biophysics.

[31]  Moyses Szklo,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[32]  C. Ge,et al.  Transcriptional regulation of osteoblasts. , 2007, Annals of the New York Academy of Sciences.

[33]  J. Ha,et al.  Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase , 2007, Experimental & Molecular Medicine.

[34]  R. Kitazawa,et al.  Modulation of mouse RANKL gene expression by Runx2 and PKA pathway , 2006, Journal of cellular biochemistry.

[35]  P. Collin‐Osdoby.  Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin , 2004, Circulation research.

[36]  William Maloney,et al.  Receptor Activator of NF-κB and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis* , 2001, The Journal of Biological Chemistry.

[37]  Y. Nishizawa,et al.  Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[38]  J. Aubin,et al.  Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate. , 1991, Bone and mineral.

[39]  T. Komori.  Regulation of osteoblast differentiation by Runx2. , 2010, Advances in experimental medicine and biology.